In English
NIDA

Search

Menu

Smoking

Receptor May Underlie Gender Differences in Response to Smoking Cessation Therapy

Men benefit more than women from nicotine replacement therapy for smoking cessation because nicotine affects a key neuroreceptor differently in the two sexes, a NIDA-sponsored study suggests. The findings highlight the need for alternative therapies for women smokers, and point to the female hormone progesterone as a potential therapeutic target.

Nicotine Makes Mouse Brain More Responsive to Cocaine

Nicotine sensitizes the mouse brain to the addictive effects of cocaine, according to recent NIDA-supported research. The results accord with the hypothesis that a person’s initial use of an addictive substance physiologically sensitizes his or her brain to the rewarding and addictive effects of other substances. If the findings carry over to people, then preventing youths from smoking might reduce their vulnerability to cocaine abuse and addiction, and cocaine-dependent individuals might ease their path to recovery by quitting smoking.

Home Visits by Nurses to Low-Income First-Time Mothers Yield Enduring Benefits

A program involving home visits by nurses to low-income first-time mothers, starting during pregnancy and extending into the second year of their children’s lives, has a positive and long-lasting impact on families. Children who participated in the program were less likely than others to report having used alcohol, cigarettes, or marijuana at age 12.

Cognitive Strategy Reduces Craving by Altering Brain Activity

While viewing images of cigarettes, smokers reported milder cravings when they shifted their focus from the pleasures of smoking to its harmful effects. Brain imaging showed a correlation between the reductions in craving and altered activity levels in regions associated with emotional regulation and reward.

Desire to Smoke Subsides, But Cigarette Cues Retain Power

During early abstinence, smokers’ cravings triggered by cigarette cues intensified over time, providing evidence that people can experience a phenomenon previously observed in experiments with animals

Research Focuses on Groups With High Smoking Rates

NIDA Director Nora Volkow
Dr. Volkow discusses NIDA’s efforts to develop effective antismoking treatments for populations with persistently high rates of smoking, such as people with psychiatric disorders, high school dropouts, and Native Americans.

In Animals, Receptor Puts Brakes on Nicotine Consumption

New research suggests that differences in tobacco consumption reflect, in part, differences in the functional efficacy of a specific type of receptor in a pathway of the brain. In animal studies, nicotinic acetylcholine receptors with the α5 subunit played a key role in producing aversive responses to nicotine, thereby dissuading further consumption of the drug.

NIDA Announces Avant-Garde Medication Development Awards

Dr. Thomas Kosten of Baylor College of Medicine and Dr. Peter Burkhard of the University of Connecticut are the recipients of NIDA’s 2011 Avant-Garde Awards for Innovative Medication Development Research. Dr. Kosten is developing a vaccine against methamphetamine abuse and Dr. Burkhard is developing a vaccine to counter nicotine addiction.

Desafío nacional sobre el Coeficiente Intelectual (IQ) de las drogas

Un examen de 12 preguntas que anima a las personas a poner a prueba su conocimiento sobre el abuso de drogas y la adicción. Las respuestas muestran el enlace entre la ciencia y el abuso de drogas.

Actualizada en: diciembre del 2012
Autor: Array

Pages

Subscribe to RSS - Smoking

Toma el reto nacional sobre el coeficiente intelectual (CI) sobre las drogas